Toxicology SIG

Objectives

To provide a forum to discuss the statistical issues involved in Regulatory and Investigative Toxicology.

Who we are

Our membership consists of statisticians at CROs, pharmaceutical companies and academia who are working in pre-clinical areas such as:

- Acute Tox
- General Tox
- Toxicokinetics
- DMPK
- ECG
- Repro Tox
- Genetic Tox
- Immuno Tox
- Toxicogenomics
- Histopathology
- Safety Pharmacology
- Carcinogenicity

We discuss diverse topics ranging from Dog Telemetry data analysis to Decision Trees, from Bayesian methods to dealing with irate study directors, and now have a list of over 50 affiliates on our e-mail distribution list.

Upcoming Events

The PSI Special Interest Group “Toxicology” have a series of regular FREE webinars dealing with statistical topics faced in toxicology and related fields. The presentations will run for an hour, with approximately 45 min presentation and a Q&A session in the remaining time. See section below for details of this years seminars.

Webinars

The PSI Special Interest Group “Toxicology” seminars for 2020 are as follows: 

Date

Title

Presenter

 Slides

14 Jan

What does the Data-Driven Hype mean for Pharma Analytics?

Richard Pugh, Mango Solutions    

 Data Driven Hype - R Pugh

31 Mar

Label-free classification of ciliated cells using Deep Learning

Ketil Tvermosegaard, GSK

 

23 Jun

Reproducibility from Discovery to Clinical Research

Bruno Boulanger, Pharmalex

 

01 Dec

TBC  

To register for a webinar please click on the link once it is available.

For all previous webinars click here.

Workshop

We are excited to announce that we will be running a workshop in 2020. It will be on the 16th and 17th March at the Crowne Plaza Hotel near Heathrow . 

The afternoon of Day 1 will include a 4.5 hour Bayesian training course focused towards applications in toxicology/pre-clinical, provided by Prof. Dr. Katja Ickstadt and is included in the workshop fee.

The member cost is £225 + VAT per delegate, inclusive of food and one night’s accommodation (and the training course). The agenda and topics that will be discussed are yet to be finalised, but please get in touch with Gareth Thomas if you have suggestions or any questions regarding the event. Full details will be circulated in the coming weeks.

Registration is open and spaces are limited.

To register, please click here. 

 

Latest News

(No updates at this time)

 

How to get in touch

Join our mailing list by e-mailing this address with brief details of the field(s) you are working in.

 


EFSPI_Logo

Upcoming Events

PSI Webinar: Master protocols - theory, application and regulatory considerations

For this webinar, PSI brings together experts on master protocols from the pharmaceutical industry, academia, and regulatory agencies.

Introduction To Industry Training Course 2020

The ITIT course will take 25 delegates new to the industry on a complete drug development experience from discovery to marketing. They will visit 6 companies to learn about 6 topics from experts in their field. The ITIT course will have 3 sessions in continental Europe and 3 sessions in the UK. The start of the 2020-2021 course will be delayed until face-to-face meetings with up to 30 people are permitted and companies are allowing travel again.

PSI Webinar: Patient preference studies

In this webinar you will hear an introduction to what a patient preference study is as well as an overview of where this type of study can inform regulatory decision making. This will be followed by 2 examples looking at potential approaches to eliciting patient preference.

PSI Vaccine SIG Webinar: Statistical Topics on COVID-19 Therapeutic and Vaccine Clinical Trials

We are delighted to be joined by Frank Harrell who will present 'Sequential Bayesian Designs for Rapid Learning in COVID-19 Therapeutic Trials'; and also by Dean Follmann, who will present on 'Statistical Aspects of COVID-19 Vaccine Trials'. Join us for this insightful and highly topical webinar.

Joint PSI, EFSPI & ASA BIOP Webinar: Estimands

PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.

Latest Jobs

Senior Research Statistician

As a member of the Statistical Sciences and Modeling (SSM) group, provide statistical technical support to projects on complex problems and methods.

Statisticians - Oncology

Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.

Therapeutic Area Global Expert Statistician - CNS & Retinopathies

You are looking for a new professional challenge - we offer you this interesting position in a global company that has been awarded several times the status of best employer.